What Researchers Found About High Blood Sugar and Cell Changes in Type 1 Diabetes
A new study examined cells in urine samples from people with Type 1 and Type 2 diabetes to understand how chronic high blood sugar might affect cells at the microscopic level.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Researchers observed more nuclear abnormalities in urothelial cells (cells lining the urinary system) from people with diabetes compared to people without diabetes
- Two factors independently predicted these cell changes: how long someone has had diabetes and how well their blood sugar has been controlled (HbA1c levels)
- While micronuclei frequency was higher in diabetic participants, this increase was not statistically significant; however, other types of nuclear changes were significantly more common
- This study adds to evidence that chronic high blood sugar may trigger cellular stress and damage, though researchers emphasize more work is needed to understand what these changes mean
Understanding the Study
Researchers at a medical center examined urine samples from 67 women: 20 with Type 1 diabetes, 25 with Type 2 diabetes, and 22 without diabetes (controls). They looked at urothelial cells—the cells that line the urinary tract—under a microscope to count and classify nuclear abnormalities, including micronuclei (tiny fragments that can form when chromosomes break).
The study was designed to test whether chronic high blood sugar contributes to chromosomal instability and cellular damage at the microscopic level. This matters because understanding how diabetes affects cells at this scale could shed light on why diabetes increases risk for certain complications.
What the Data Showed
Both people with Type 1 and Type 2 diabetes showed more nuclear abnormalities in their urothelial cells than the control group. Specifically, nuclear buds and degenerative changes were significantly more frequent in both diabetes groups.
Micronuclei—the main focus of the study—appeared more often in people with diabetes overall, but this increase did not reach statistical significance. In other words, the difference was larger than chance alone would explain for some measures, but not for micronuclei specifically.
When the researchers compared Type 1 and Type 2 diabetes directly, Type 2 participants showed significantly higher frequencies of certain types of nuclear anomalies than Type 1 participants. This may reflect differences in disease duration and metabolic profiles between the two groups.
What Predicted Cell Changes
The researchers used statistical analysis to identify which factors best predicted the formation of micronuclei. Two factors stood out: longer diabetes duration and higher HbA1c levels (a measure of average blood sugar control over three months). Both factors independently predicted micronuclei formation, meaning each contributed separately to the likelihood of observing these cell changes.
This finding supports the idea that chronic high blood sugar—captured by both how long someone has had diabetes and how well controlled their blood sugar is—may drive cellular damage and chromosomal instability.
What This Means and What's Still Unknown
This study adds evidence that chronic high blood sugar is associated with measurable changes in cells at the microscopic level. The connection between blood sugar control and cell damage aligns with what researchers know about how hyperglycemia can trigger oxidative stress and cellular harm.
However, this study does not explain what these nuclear abnormalities mean for a person's health or whether they directly cause diabetes complications. The research was conducted in a small group of women, so findings may not apply to everyone. More research is needed to understand whether these cell changes are reversible, whether they contribute to specific complications, and whether interventions that improve blood sugar control can prevent or reverse them.
Evidence label
Source: Mutation research. Genetic toxicology and environmental mutagenesis. Evidence type: PubMed indexed literature. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryCauses & What We KnowPregnant Women with Diabetes Show Higher Rates of Toxoplasma InfectionPubMed indexed literature
- Research summaryCauses & What We KnowExploring Rare Breast Inflammation: What BRCA Mutations and Type 1 Diabetes May SharePubMed indexed literature
- Research summaryCauses & What We KnowUnderstanding Type 1 Diabetes: A Shift Toward Early InterventionPubMed indexed literature
- Research summaryCauses & What We KnowHow Nutrition, Metabolism, and Immunity Connect: What the Lectin Pathway Tells UsPubMed indexed literature
- Research summaryCauses & What We KnowHow Gut Bacteria May Influence the Intestinal Barrier in Type 1 DiabetesPubMed indexed literature
- Research summaryCauses & What We KnowLiver Changes in Cystic Fibrosis: What a New Study FoundPubMed indexed literature